Authors: Cherington, V Higgins, C

Citation: V. Cherington et C. Higgins, Using retroviral vectors to express SV40 tumor antigens, METH MOL B, 165, 2001, pp. 129-150

Authors: Higgins, C Cherington, V

Citation: C. Higgins et V. Cherington, Methods to assess inhibition of adipocyte differentiation by SV40 large T antigen, METH MOL B, 165, 2001, pp. 165-183

Authors: Chiang, GG Rubin, HL Cherington, V Wang, T Sobolewski, J McGrath, CA Gaffney, A Emami, S Sarver, N Levine, PH Greenberger, JS Hurwitz, DR

Citation: Gg. Chiang et al., Bone marrow stromal cell-mediated gene therapy for hemophilia A: In vitro expression of human factor VIII with high biological activity requires the inclusion of the proteolytic site at amino acid 1648, HUM GENE TH, 10(1), 1999, pp. 61-76

Authors: Powers, JF Tischler, AS Cherington, V

Citation: Jf. Powers et al., Discordant effects of rapamycin on proliferation and p70S6 kinase phosphorylation in normal and neoplastic rat chromaffin cells, NEUROSCI L, 259(3), 1999, pp. 137-140

Authors: Yen, A Cherington, V Schaffhausen, B Marks, K Varvayanis, S

Citation: A. Yen et al., Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T, EXP CELL RE, 248(2), 1999, pp. 538-551